Literature DB >> 24798398

Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.

Iraj Ragerdi Kashani1, Zahra Rajabi, Mohammad Akbari, Gholamreza Hassanzadeh, Alireza Mohseni, Mohammadtaha Kouchakinejad Eramsadati, Kheirollah Rafiee, Cordian Beyer, Markus Kipp, Adib Zendedel.   

Abstract

Multiple sclerosis (MS) is the most prevalent inflammatory demyelinating disease of the central nervous system. Besides other pathophysiological mechanisms, mitochondrial injury is crucially involved in the development and progression of this disease. Mitochondria have been identified as targets for the peptide hormone melatonin. In the present study, we sought to evaluate the impact of oxidative stress on mitochondrial density and enzyme transcription during experimentally induced demyelination and the protective influence of melatonin. Adult male mice were fed with cuprizone for 5 weeks which caused severe demyelination of the corpus callosum (CC). Animals were simultaneously treated with melatonin by daily intra-peritoneal injections. Melatonin exposure reversed cuprizone-induced demyelination and axon protection. Transmission electron microscopy demonstrated significantly increased mitochondrial numbers and slightly increased mitochondrial size within CC axons after cuprizone exposure. Melatonin antagonized these effects and, in addition, induced the expression of subunits of the respiratory chain complex over normal control values reflecting a mechanism to compensate cuprizone-mediated down-regulation of these genes. Similarly, melatonin modulated gene expression of mitochondrial fusion and fission proteins. Biochemical analysis showed that oxidative stress induced by cuprizone was regulated by melatonin. The data implicate that melatonin abolishes destructive cuprizone effects in the CC by decreasing oxidative stress, restoring mitochondrial respiratory enzyme activity and fusion and fission processes as well as decreasing intra-axonal mitochondria accumulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798398     DOI: 10.1007/s00221-014-3946-5

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  50 in total

1.  Shift work at young age is associated with increased risk for multiple sclerosis.

Authors:  Anna Karin Hedström; Torbjörn Åkerstedt; Jan Hillert; Tomas Olsson; Lars Alfredsson
Journal:  Ann Neurol       Date:  2011-10-17       Impact factor: 10.422

2.  Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats.

Authors:  D Ozdemir; N Uysal; S Gonenc; O Acikgoz; A Sonmez; A Topcu; N Ozdemir; M Duman; I Semin; H Ozkan
Journal:  Physiol Res       Date:  2005       Impact factor: 1.881

Review 3.  Therapeutic prospects for mitochondrial disease.

Authors:  Eric A Schon; Salvatore DiMauro; Michio Hirano; Robert W Gilkerson
Journal:  Trends Mol Med       Date:  2010-06       Impact factor: 11.951

4.  Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yi Zhang; Anna Cook; Jinho Kim; Sergei V Baranov; Jiying Jiang; Karen Smith; Kerry Cormier; Erik Bennett; Robert P Browser; Arthur L Day; Diane L Carlisle; Robert J Ferrante; Xin Wang; Robert M Friedlander
Journal:  Neurobiol Dis       Date:  2013-03-26       Impact factor: 5.996

5.  Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis.

Authors:  Yang-ja Lee; Seon-Yong Jeong; Mariusz Karbowski; Carolyn L Smith; Richard J Youle
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

Review 6.  The cuprizone animal model: new insights into an old story.

Authors:  Markus Kipp; Tim Clarner; Jon Dang; Sjef Copray; Cordian Beyer
Journal:  Acta Neuropathol       Date:  2009-09-18       Impact factor: 17.088

7.  Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes.

Authors:  Xia Shen; Shirong Zheng; Visith Thongboonkerd; Ming Xu; William M Pierce; Jon B Klein; Paul N Epstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07-27       Impact factor: 4.310

8.  Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats.

Authors:  Charanjit Kaur; Viswanathan Sivakumar; Remya Robinson; Wallace S Foulds; Chi D Luu; Eng-Ang Ling
Journal:  J Pineal Res       Date:  2012-11-01       Impact factor: 13.007

Review 9.  Cuprizone-induced demyelination as a tool to study remyelination and axonal protection.

Authors:  Adib Zendedel; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2013-05-12       Impact factor: 3.444

Review 10.  Mitochondrial changes within axons in multiple sclerosis: an update.

Authors:  Graham R Campbell; Nobuhiko Ohno; Doug M Turnbull; Don J Mahad
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

View more
  16 in total

1.  The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Amir Ghaemi; Farshid Noorbakhsh; Mohammad Sharifzadeh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

2.  Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.

Authors:  Guiyun Mi; Yunyun Gao; Shuai Liu; Enmao Ye; Yanyan Li; Xiao Jin; Hongju Yang; Zheng Yang
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

3.  Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis.

Authors:  Simone Kern; Michael Geiger; Madlen Paucke; Alina Kästner; Katja Akgün; Tjalf Ziemssen
Journal:  J Mol Med (Berl)       Date:  2019-08-30       Impact factor: 4.599

4.  Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.

Authors:  Adib Zendedel; Iraj Ragerdi Kashani; Maryam Azimzadeh; Parichehr Pasbakhsh; Negar Omidi; Abolfazl Golestani; Cordian Beyer; Tim Clarner
Journal:  Metab Brain Dis       Date:  2016-01-04       Impact factor: 3.584

Review 5.  Sex differences in mitochondrial (dys)function: Implications for neuroprotection.

Authors:  Tyler G Demarest; Margaret M McCarthy
Journal:  J Bioenerg Biomembr       Date:  2014-10-08       Impact factor: 2.945

Review 6.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

Review 7.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

8.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18

9.  Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.

Authors:  Jie Wen; Prasanth S Ariyannur; Rachel Ribeiro; Mikiei Tanaka; John R Moffett; Batool F Kirmani; Aryan M A Namboodiri; Yumin Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

10.  Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity.

Authors:  Ting Long; Yuan Yang; Ling Peng; Zuoxiao Li
Journal:  J Mol Neurosci       Date:  2018-02-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.